NanoViricides (NNVC) Competitors $1.46 -0.10 (-6.41%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.48 +0.02 (+1.37%) As of 06:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock NNVC vs. ADAG, CRVO, TCRX, IMAB, JMAC, INZY, CRBU, ADAP, GNTA, and XCURShould you be buying NanoViricides stock or one of its competitors? The main competitors of NanoViricides include Adagene (ADAG), CervoMed (CRVO), TScan Therapeutics (TCRX), I-Mab (IMAB), Maxpro Capital Acquisition (JMAC), Inozyme Pharma (INZY), Caribou Biosciences (CRBU), Adaptimmune Therapeutics (ADAP), Genenta Science (GNTA), and Exicure (XCUR). These companies are all part of the "pharmaceutical products" industry. NanoViricides vs. Adagene CervoMed TScan Therapeutics I-Mab Maxpro Capital Acquisition Inozyme Pharma Caribou Biosciences Adaptimmune Therapeutics Genenta Science Exicure NanoViricides (NYSE:NNVC) and Adagene (NASDAQ:ADAG) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership. Does the MarketBeat Community believe in NNVC or ADAG? Adagene received 23 more outperform votes than NanoViricides when rated by MarketBeat users. Likewise, 79.31% of users gave Adagene an outperform vote while only 0.00% of users gave NanoViricides an outperform vote. CompanyUnderperformOutperformNanoViricidesOutperform VotesNo VotesUnderperform Votes57100.00% AdageneOutperform Votes2379.31% Underperform Votes620.69% Which has higher valuation & earnings, NNVC or ADAG? NanoViricides has higher earnings, but lower revenue than Adagene. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNanoViricidesN/AN/A-$8.29M-$0.70-2.09Adagene$103.20K757.75-$18.95MN/AN/A Which has more volatility & risk, NNVC or ADAG? NanoViricides has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, Adagene has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. Do institutionals & insiders have more ownership in NNVC or ADAG? 10.3% of NanoViricides shares are owned by institutional investors. Comparatively, 9.5% of Adagene shares are owned by institutional investors. 4.6% of NanoViricides shares are owned by insiders. Comparatively, 21.2% of Adagene shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is NNVC or ADAG more profitable? Adagene's return on equity of 0.00% beat NanoViricides' return on equity.Company Net Margins Return on Equity Return on Assets NanoViricidesN/A -87.90% -78.69% Adagene N/A N/A N/A Do analysts rate NNVC or ADAG? Adagene has a consensus price target of $8.00, indicating a potential upside of 381.93%. Given Adagene's stronger consensus rating and higher possible upside, analysts plainly believe Adagene is more favorable than NanoViricides.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NanoViricides 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Adagene 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media refer more to NNVC or ADAG? In the previous week, NanoViricides had 1 more articles in the media than Adagene. MarketBeat recorded 1 mentions for NanoViricides and 0 mentions for Adagene. Adagene's average media sentiment score of 0.00 beat NanoViricides' score of -0.03 indicating that Adagene is being referred to more favorably in the news media. Company Overall Sentiment NanoViricides Neutral Adagene Neutral SummaryAdagene beats NanoViricides on 10 of the 14 factors compared between the two stocks. Get NanoViricides News Delivered to You Automatically Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNVC vs. The Competition Export to ExcelMetricNanoViricidesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$25.07M$6.52B$5.37B$19.41BDividend YieldN/A2.65%5.22%3.83%P/E Ratio-2.038.9226.8434.23Price / SalesN/A253.80392.3434.85Price / CashN/A65.8538.2517.51Price / Book2.216.466.794.69Net Income-$8.29M$143.98M$3.23B$1.02B7 Day Performance11.45%2.03%1.53%-1.74%1 Month Performance8.96%4.11%10.06%7.46%1 Year Performance-34.53%-2.87%16.72%3.96% NanoViricides Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNVCNanoViricidesN/A$1.46-6.4%N/A-33.6%$25.07MN/A-2.0320ADAGAdagene2.3111 of 5 stars$1.70+6.2%$8.00+370.9%-35.9%$80.04M$103,204.000.00260Positive NewsGap UpCRVOCervoMed3.3162 of 5 stars$9.10+7.2%$27.50+202.2%-56.2%$79.20M$7.14M-4.484TCRXTScan Therapeutics3.9397 of 5 stars$1.37+7.9%$8.50+520.4%-85.8%$77.53M$4.42M-1.29100Positive NewsInsider TradeIMABI-Mab3.1896 of 5 stars$0.95+7.4%$5.50+482.0%-46.4%$77.02M$3.27M0.00380News CoverageJMACMaxpro Capital AcquisitionN/A$5.68flatN/A+1,580.3%$76.27MN/A0.002,021Gap UpINZYInozyme Pharma2.8857 of 5 stars$1.18+2.6%$14.63+1,139.4%-16.0%$76.18MN/A-0.7650CRBUCaribou Biosciences2.7565 of 5 stars$0.82+5.7%$9.33+1,040.9%-67.2%$76.09M$9.99M-0.50100ADAPAdaptimmune Therapeutics2.7357 of 5 stars$0.30+0.9%$1.83+519.9%-74.5%$75.94M$178.03M-1.34490GNTAGenenta Science1.4964 of 5 stars$4.13-5.0%$25.00+506.1%+38.7%$75.45MN/A0.007Gap UpXCURExicure1.4614 of 5 stars$11.86+3.7%N/A+2,082.5%$74.93M$500,000.00-5.7350Gap Up Related Companies and Tools Related Companies Adagene Alternatives CervoMed Alternatives TScan Therapeutics Alternatives I-Mab Alternatives Maxpro Capital Acquisition Alternatives Inozyme Pharma Alternatives Caribou Biosciences Alternatives Adaptimmune Therapeutics Alternatives Genenta Science Alternatives Exicure Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NNVC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NNVC Stock Free NNVC Stock Alerts